Association between neuroimaging and clinical outcomes in individuals with central nervous system cryptococcosis
- PMID: 39004801
- DOI: 10.1111/myc.13767
Association between neuroimaging and clinical outcomes in individuals with central nervous system cryptococcosis
Abstract
Background: The radiological manifestations of central nervous system (CNS) cryptococcosis are diverse and often subtle. There is heterogeneity on how different neuroimaging patterns impact prognosis. This study aims to assess the association between the neuroimaging and clinical outcomes of CNS cryptococcosis.
Methods: All patients with CNS cryptococcosis between July 2017 and April 2023 who underwent brain magnetic resonance imaging (MRI) were included. The primary outcome was mortality during hospitalisation. Secondary outcomes were readmission, ventricular shunting, duration of hospitalisation and time to the first negative cerebrospinal fluid culture. We compared the outcomes for each of the five main radiological findings on the brain MRI scan.
Results: We included 46 proven CNS cryptococcosis cases. The two main comorbidity groups were HIV infection (20, 43%) and solid organ transplantation (10, 22%), respectively. Thirty-nine patients exhibited at least one radiological abnormality (85%), with the most common being meningeal enhancement (34, 74%). The mortality rates occurred at 11% (5/46) during hospitalisation. We found no significant disparities in mortality related to distinct radiological patterns. The presence of pseudocysts was significantly associated with the need for readmission (p = .027). The ventricular shunting was significantly associated with the presence of pseudocysts (p = .005) and hydrocephalus (p = .044).
Conclusion: In this study, there is no association between brain MRI findings and mortality. Larger studies are needed to evaluate this important issue.
Keywords: central nervous system; cryptococcosis; diagnosis; magnetic resonance imaging; outcome.
© 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV‐1‐infected Ugandan adults. AIDS. 2002;16(7):1031‐1038. doi:10.1097/00002030-200205030-00009
-
- Mitchell DH, Sorrell TC, Allworth AM, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis. 1995;20(3):611‐616. doi:10.1093/clinids/20.3.611
-
- Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV‐associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;17(8):873‐881. doi:10.1016/S1473-3099(17)30243-8
-
- Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic‐pathologic correlation. Radiographics. 2008;28(7):2033‐2058. doi:10.1148/rg.287085135
-
- Loyse A, Moodley A, Rich P, et al. Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV‐associated cryptococcal meningoencephalitis. J Infect. 2015;70(6):668‐675. doi:10.1016/j.jinf.2014.10.007
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
